- Article
Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration
- Arslan Babar,
- Neil M. Woody,
- Ahmed I. Ghanem,
- Jillian Tsai,
- Neal E. Dunlap,
- Matthew Schymick,
- Howard Y. Liu,
- Brian B. Burkey,
- Eric D. Lamarre and
- Jamie A. Ku
- + 11 authors
Adjuvant chemoradiation (CRT), with high-dose cisplatin remains standard treatment for oral cavity squamous cell carcinoma (OCSCC) with high-risk pathologic features. We evaluated outcomes associated with different cisplatin dosing and schedules, con...